Hong Kong Stock Exchange filings reveal that on August 31st, HTF Fund Management Co., Ltd. acquired an additional 30,800 shares of SKB BIO (06990). The transaction was executed at a price of HK$492.9088 per share, amounting to a total consideration of approximately HK$15.18 million. Following this purchase, the fund's accumulated holding in the biopharmaceutical company now stands at 8.87 million shares, representing a 5.01% stake in the company.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.